Mobile Platform for Optimizing Wellness and Engagement in Recovery

Not Applicable

Not yet recruiting

• Conditions: Opioid Agonist Treatment; Alcohol Use Disorder; Opioid Use Disorder

• Registration Number: NCT07178990
• Lead Sponsor: University of Michigan

Brief Summary

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-09
• Study First Submitted: 2025-09-10
• Study First Submitted QC: 2025-09-10
• Last Update Submitted: 2025-09-10
• Study First Posted: 2025-09-17
• Last Update Posted: 2025-09-17
• Study Start: 2025-10-01
• Primary Completion: 2027-07-01
• Study Completion: 2027-07-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Participants must be enrolled in the Michigan Medicaid program
• Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
• Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
• Participants must have regular access to a working smartphone and internet connection.
• Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).

Exclusion Criteria

• Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
• Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
• Individuals with substantial cognitive impairment that would interfere with study participation
• Individuals unable to read or understand English
• Individuals experiencing active suicidality or psychosis.
• Individuals with a planned admission to residential treatment or incarceration during the study period.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Feasibility based on recruitment	Recruitment period 12 months	Recruitment: ≥60% of participants enrolled
Feasibility based on adherence	6 months (during the Dynamicare program)	Adherence: ≥50% of app-based, biochemically-verified tests completed in the digital CM condition.
Feasibility based on Retention	6 months	Retention: ≥70% of participants retained at 6 months
Acceptability of the intervention	3-month after starting program	Defined as \>70% of participants rating the intervention experience ≥ 4/5 on the Acceptability of Intervention Measure

Trial Locations

Locations (1)

University of Michigan; 🇺🇸 Ann Arbor, Michigan, United States